Phenolic Compounds as Preventive and Therapeutic Agents in Diabetes-Related Oxidative Stress, Inflammation, Advanced Glycation End-Products Production and Insulin Sensitivity

Diabetes mellitus and its complications represent an extremely concerning health problem across the world. The extraordinary worldwide increase of the disease incidence highlights a challenging need for the development of new, safe, effective, and affordable therapeutic approaches. This complex dise...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Discovery medicine 2023-10, Vol.35 (178), p.715-732
Hauptverfasser: Pannucci, Elisa, Spagnuolo, Ludovica, De Gara, Laura, Santi, Luca, Dugo, Laura
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 732
container_issue 178
container_start_page 715
container_title Discovery medicine
container_volume 35
creator Pannucci, Elisa
Spagnuolo, Ludovica
De Gara, Laura
Santi, Luca
Dugo, Laura
description Diabetes mellitus and its complications represent an extremely concerning health problem across the world. The extraordinary worldwide increase of the disease incidence highlights a challenging need for the development of new, safe, effective, and affordable therapeutic approaches. This complex disease, characterized by high blood sugar levels, involves numerous pathogenic processes in its etiology. Even though the molecular mechanisms behind are not clear, it is broadly recognized that oxidative stress, the accumulation of advanced glycation end-products (AGEs) and inflammation are implicated in the development, the progression and the related complications of the disease. In this regard, phenolic compounds represent a valuable therapeutic perspective. Thus, this review is focused on the role of phenolic compounds in diabetes-related oxidative stress, AGEs production and inflammation. In particular, we summarized recent results of in vitro and in vivo studies concerning antioxidant and antiglycative properties of phenolic compounds and also the modulation of activity on inflammation and inflammation-related pathways relevant in diabetes, namely arachidonic acid, nuclear factor-κB, mitogen-activated protein kinases and phosphatidylinositol 3‑kinase/protein kinase B signaling pathways, were described. Highlighting thus the anti-diabetic potential of phenolic compounds in the development of preventive or therapeutic strategies for the management of diabetes and its related complications.
doi_str_mv 10.24976/Discov.Med.202335178.68
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2874839268</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2874839268</sourcerecordid><originalsourceid>FETCH-LOGICAL-c167t-bb84c7cce939bfc7a92d33692e7abb1f0a458096004c70ad2dc0bde49267ef663</originalsourceid><addsrcrecordid>eNo9kU1u2zAQhYWgBZK6vQOXWUQOJUr8WRq2kxpwEaNJ1wRFjhIWEumSlFFfqmcMbQddzeDNN_OAeUWBKjyvG8Ho_cpG7Q_zH2DmNa4JaSvG55RfFTeVaJqSCYI_5b4loqQtFtfFlxh_Y0w44e1N8W_3Bs4PVqOlH_d-ciYiFdEuwAFcsgdAyhn08gZB7WFKmVu85kFE1qGVVR0kiOVPGFQCg57-WqPOS88pQIx3aOP6QY1jFr27QwtzUE5n8HE46rOG1s6Uu-DNpNPJ9dyc9JPrxsVpyD7P4KLNZ206fi0-92qI8O2jzopfD-uX5fdy-_S4WS62pa4oS2XX8UYzrUEQ0fWaKVEbQqiogamuq3qsmpZjQTHOGFamNhp3BhpRUwY9pWRW3F7u7oP_M0FMcsxvhmFQDvwUZc1Zw0nGeUb5BdXBxxigl_tgRxWOssLyHJG8RCRzRPJ_RDKvvgPww4x-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2874839268</pqid></control><display><type>article</type><title>Phenolic Compounds as Preventive and Therapeutic Agents in Diabetes-Related Oxidative Stress, Inflammation, Advanced Glycation End-Products Production and Insulin Sensitivity</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Pannucci, Elisa ; Spagnuolo, Ludovica ; De Gara, Laura ; Santi, Luca ; Dugo, Laura</creator><creatorcontrib>Pannucci, Elisa ; Spagnuolo, Ludovica ; De Gara, Laura ; Santi, Luca ; Dugo, Laura</creatorcontrib><description>Diabetes mellitus and its complications represent an extremely concerning health problem across the world. The extraordinary worldwide increase of the disease incidence highlights a challenging need for the development of new, safe, effective, and affordable therapeutic approaches. This complex disease, characterized by high blood sugar levels, involves numerous pathogenic processes in its etiology. Even though the molecular mechanisms behind are not clear, it is broadly recognized that oxidative stress, the accumulation of advanced glycation end-products (AGEs) and inflammation are implicated in the development, the progression and the related complications of the disease. In this regard, phenolic compounds represent a valuable therapeutic perspective. Thus, this review is focused on the role of phenolic compounds in diabetes-related oxidative stress, AGEs production and inflammation. In particular, we summarized recent results of in vitro and in vivo studies concerning antioxidant and antiglycative properties of phenolic compounds and also the modulation of activity on inflammation and inflammation-related pathways relevant in diabetes, namely arachidonic acid, nuclear factor-κB, mitogen-activated protein kinases and phosphatidylinositol 3‑kinase/protein kinase B signaling pathways, were described. Highlighting thus the anti-diabetic potential of phenolic compounds in the development of preventive or therapeutic strategies for the management of diabetes and its related complications.</description><identifier>ISSN: 1539-6509</identifier><identifier>EISSN: 1944-7930</identifier><identifier>DOI: 10.24976/Discov.Med.202335178.68</identifier><language>eng</language><ispartof>Discovery medicine, 2023-10, Vol.35 (178), p.715-732</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Pannucci, Elisa</creatorcontrib><creatorcontrib>Spagnuolo, Ludovica</creatorcontrib><creatorcontrib>De Gara, Laura</creatorcontrib><creatorcontrib>Santi, Luca</creatorcontrib><creatorcontrib>Dugo, Laura</creatorcontrib><title>Phenolic Compounds as Preventive and Therapeutic Agents in Diabetes-Related Oxidative Stress, Inflammation, Advanced Glycation End-Products Production and Insulin Sensitivity</title><title>Discovery medicine</title><description>Diabetes mellitus and its complications represent an extremely concerning health problem across the world. The extraordinary worldwide increase of the disease incidence highlights a challenging need for the development of new, safe, effective, and affordable therapeutic approaches. This complex disease, characterized by high blood sugar levels, involves numerous pathogenic processes in its etiology. Even though the molecular mechanisms behind are not clear, it is broadly recognized that oxidative stress, the accumulation of advanced glycation end-products (AGEs) and inflammation are implicated in the development, the progression and the related complications of the disease. In this regard, phenolic compounds represent a valuable therapeutic perspective. Thus, this review is focused on the role of phenolic compounds in diabetes-related oxidative stress, AGEs production and inflammation. In particular, we summarized recent results of in vitro and in vivo studies concerning antioxidant and antiglycative properties of phenolic compounds and also the modulation of activity on inflammation and inflammation-related pathways relevant in diabetes, namely arachidonic acid, nuclear factor-κB, mitogen-activated protein kinases and phosphatidylinositol 3‑kinase/protein kinase B signaling pathways, were described. Highlighting thus the anti-diabetic potential of phenolic compounds in the development of preventive or therapeutic strategies for the management of diabetes and its related complications.</description><issn>1539-6509</issn><issn>1944-7930</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNo9kU1u2zAQhYWgBZK6vQOXWUQOJUr8WRq2kxpwEaNJ1wRFjhIWEumSlFFfqmcMbQddzeDNN_OAeUWBKjyvG8Ho_cpG7Q_zH2DmNa4JaSvG55RfFTeVaJqSCYI_5b4loqQtFtfFlxh_Y0w44e1N8W_3Bs4PVqOlH_d-ciYiFdEuwAFcsgdAyhn08gZB7WFKmVu85kFE1qGVVR0kiOVPGFQCg57-WqPOS88pQIx3aOP6QY1jFr27QwtzUE5n8HE46rOG1s6Uu-DNpNPJ9dyc9JPrxsVpyD7P4KLNZ206fi0-92qI8O2jzopfD-uX5fdy-_S4WS62pa4oS2XX8UYzrUEQ0fWaKVEbQqiogamuq3qsmpZjQTHOGFamNhp3BhpRUwY9pWRW3F7u7oP_M0FMcsxvhmFQDvwUZc1Zw0nGeUb5BdXBxxigl_tgRxWOssLyHJG8RCRzRPJ_RDKvvgPww4x-</recordid><startdate>20231001</startdate><enddate>20231001</enddate><creator>Pannucci, Elisa</creator><creator>Spagnuolo, Ludovica</creator><creator>De Gara, Laura</creator><creator>Santi, Luca</creator><creator>Dugo, Laura</creator><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20231001</creationdate><title>Phenolic Compounds as Preventive and Therapeutic Agents in Diabetes-Related Oxidative Stress, Inflammation, Advanced Glycation End-Products Production and Insulin Sensitivity</title><author>Pannucci, Elisa ; Spagnuolo, Ludovica ; De Gara, Laura ; Santi, Luca ; Dugo, Laura</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c167t-bb84c7cce939bfc7a92d33692e7abb1f0a458096004c70ad2dc0bde49267ef663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pannucci, Elisa</creatorcontrib><creatorcontrib>Spagnuolo, Ludovica</creatorcontrib><creatorcontrib>De Gara, Laura</creatorcontrib><creatorcontrib>Santi, Luca</creatorcontrib><creatorcontrib>Dugo, Laura</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Discovery medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pannucci, Elisa</au><au>Spagnuolo, Ludovica</au><au>De Gara, Laura</au><au>Santi, Luca</au><au>Dugo, Laura</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phenolic Compounds as Preventive and Therapeutic Agents in Diabetes-Related Oxidative Stress, Inflammation, Advanced Glycation End-Products Production and Insulin Sensitivity</atitle><jtitle>Discovery medicine</jtitle><date>2023-10-01</date><risdate>2023</risdate><volume>35</volume><issue>178</issue><spage>715</spage><epage>732</epage><pages>715-732</pages><issn>1539-6509</issn><eissn>1944-7930</eissn><abstract>Diabetes mellitus and its complications represent an extremely concerning health problem across the world. The extraordinary worldwide increase of the disease incidence highlights a challenging need for the development of new, safe, effective, and affordable therapeutic approaches. This complex disease, characterized by high blood sugar levels, involves numerous pathogenic processes in its etiology. Even though the molecular mechanisms behind are not clear, it is broadly recognized that oxidative stress, the accumulation of advanced glycation end-products (AGEs) and inflammation are implicated in the development, the progression and the related complications of the disease. In this regard, phenolic compounds represent a valuable therapeutic perspective. Thus, this review is focused on the role of phenolic compounds in diabetes-related oxidative stress, AGEs production and inflammation. In particular, we summarized recent results of in vitro and in vivo studies concerning antioxidant and antiglycative properties of phenolic compounds and also the modulation of activity on inflammation and inflammation-related pathways relevant in diabetes, namely arachidonic acid, nuclear factor-κB, mitogen-activated protein kinases and phosphatidylinositol 3‑kinase/protein kinase B signaling pathways, were described. Highlighting thus the anti-diabetic potential of phenolic compounds in the development of preventive or therapeutic strategies for the management of diabetes and its related complications.</abstract><doi>10.24976/Discov.Med.202335178.68</doi><tpages>18</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1539-6509
ispartof Discovery medicine, 2023-10, Vol.35 (178), p.715-732
issn 1539-6509
1944-7930
language eng
recordid cdi_proquest_miscellaneous_2874839268
source EZB-FREE-00999 freely available EZB journals
title Phenolic Compounds as Preventive and Therapeutic Agents in Diabetes-Related Oxidative Stress, Inflammation, Advanced Glycation End-Products Production and Insulin Sensitivity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T02%3A06%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phenolic%20Compounds%20as%20Preventive%20and%20Therapeutic%20Agents%20in%20Diabetes-Related%20Oxidative%20Stress,%20Inflammation,%20Advanced%20Glycation%20End-Products%20Production%20and%20Insulin%20Sensitivity&rft.jtitle=Discovery%20medicine&rft.au=Pannucci,%20Elisa&rft.date=2023-10-01&rft.volume=35&rft.issue=178&rft.spage=715&rft.epage=732&rft.pages=715-732&rft.issn=1539-6509&rft.eissn=1944-7930&rft_id=info:doi/10.24976/Discov.Med.202335178.68&rft_dat=%3Cproquest_cross%3E2874839268%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2874839268&rft_id=info:pmid/&rfr_iscdi=true